View all reports
Y-mAbs Therapeutics, Inc. (YMAB) stock forecast and price target
Find the latest Y-mAbs Therapeutics, Inc. YMAB analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Date Range
investment rating
report type
sector
industry
provider
YMABY-mAbs Therapeutics, Inc.15.24 -0.05 (-0.33%)
As of 02:17PM . Market open.
Recommendation Rating
2.1
Analyst Price Targets (7)
Current 15.24
Average 21.43
Low 12.00
High 26.00
Related Research Reports1-4 of 4 results
| Report Name | Symbols | Sector | Provider | Date | |
|---|---|---|---|---|---|
| GRND,MSFT,TJX,F,LMAT,PLSE,YMAB,VERX,IBOC,NEE | Utilities,Financial Services,Technology,Healthcare,Consumer Cyclical | Argus | Dec 12, 2023 | Upgrade to begin downloading full reports | |
| SKX,CRWD,SGHT,ATEX,RCL,PLSE,YMAB,VERX,SRBK,RJF | Communication Services,Financial Services,Technology,Healthcare,Consumer Cyclical | Argus | Dec 04, 2023 | Upgrade to begin downloading full reports | |
| APP,ABR,TTEK,FI,DDD,NOW,WEST,YMAB,FMC | Basic Materials,Technology,Real Estate,Healthcare,Industrials,Consumer Defensive | Argus | Nov 30, 2023 | Upgrade to begin downloading full reports | |
| MSFT,RILY,PARA,RETA,EL,AXON,BMEA,SLQT,YMAB,CLH | Communication Services,Financial Services,Technology,Healthcare,Industrials,Consumer Defensive | Argus | May 18, 2023 | Upgrade to begin downloading full reports |